NCT02432287View on ClinicalTrials.gov

Metformin in Longevity Study (MILES).

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2017

Conditions
Aging
Interventions
DRUG

Metformin

To determine if treatment with metformin (1700 mg/day) will restore the gene expression profile of older, glucose intolerant adults to that of young healthy subjects.

DRUG

Placebo

there is no other name we used for the placebo

Trial Locations (1)

10461

Einstein College of Medicine of Yeshiva University, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER

NCT02432287 - Metformin in Longevity Study (MILES). | Biotech Hunter | Biotech Hunter